- In April 2025, Avulux migraine glasses, developed with optical technology to manage photophobia, joined the FDA-funded CTIP pediatric medical device accelerator program in the U.S.
- In November 2024, Novoxel Inc. launched Tixel i in the U.S. after FDA clearance. This two-minute Thermo-Mechanical Action treatment significantly reduced dry eye symptoms for patients with Meibomian Gland Dysfunction.
